marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-09-2023
Evelo Biosciences Financial Ratios 2011-2024 | EVLO
Annual Financial Ratios Evelo Biosciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -2.0 | -8.8 | -2.5 | -3.5 | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.3 | -2.3 | -2.4 | -2.7 | -2.8 | -9.1 | -5.3 | - | - | - | - | - |
EV (Enterprise Value) |
48.5 M | 260 M | 811 M | 169 M | 132 M | -25.4 M | -2.74 M | - | - | - | - | - |
EBITDA per Share |
-1.22 | -2.14 | -1.92 | -2.64 | -2.57 | - | - | - | - | - | - | - |
EV/EBITDA |
-2.0 | -8.7 | -1.9 | -2.2 | - | - | - | - | - | - | - | |
PEG |
- | 0.92 | -0.64 | 0.04 | - | - | - | - | - | - | - | |
P/B |
-5.4 | 28.8 | 26.9 | 3.6 | 1.5 | - | - | - | - | - | - | - |
P/CF |
-0.3 | -2.6 | -11.0 | -2.9 | -3.8 | - | - | - | - | - | - | - |
ROE % |
2294.21 | -1409.67 | -307.25 | -141.99 | -41.58 | - | - | - | - | - | - | - |
ROA % |
-177.72 | -139.04 | -103.34 | -94.01 | -35.62 | - | - | - | - | - | - | - |
ROCE % |
2172.80 | -1331.44 | -129.77 | -106.38 | -38.57 | - | - | - | - | - | - | - |
Current Ratio |
0.9 | 1.1 | 3.6 | 8.3 | 16.4 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Evelo Biosciences
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.71 | -3.78 | -0.23 | - | -5.66 | -8.07 | -0.56 | - | -0.63 | -0.59 | -0.55 | - | -0.45 | -0.63 | -0.71 | -0.7 | -0.67 | -0.65 | -0.64 | -0.49 | -0.5 | -0.85 | -3.29 | -2.57 | -2.61 | -2.09 | -1.81 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.63 | -3.44 | -0.22 | - | -5.29 | -7.68 | -0.53 | - | -0.58 | -0.51 | -0.52 | - | -0.43 | -0.61 | -0.71 | - | -0.65 | -0.65 | -0.64 | - | -0.51 | -0.74 | -2.51 | - | -2.07 | -1.61 | -1.38 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-142.88 | -516.62 | -648.10 | -235.46 | -337.43 | -111.96 | -77.12 | -184.97 | -253.60 | -220.26 | -237.11 | -211.96 | -249.50 | -216.80 | -183.85 | -141.99 | -115.72 | -91.36 | -67.64 | -41.58 | -15.43 | 11.09 | 33.77 | 51.25 | 36.37 | 21.44 | 9.81 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-257.09 | -232.55 | -158.49 | -113.47 | -142.44 | -136.00 | -130.47 | -69.17 | -92.25 | -86.37 | -87.38 | -71.29 | -96.15 | -96.85 | -97.10 | -94.01 | -78.81 | -64.94 | -51.38 | -35.62 | -44.56 | -53.30 | -58.36 | -64.05 | -45.46 | -26.79 | -12.26 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-136.05 | -489.19 | -614.62 | -223.23 | -322.12 | -109.75 | -71.29 | -174.71 | -240.91 | -208.22 | -230.09 | -208.92 | -244.63 | -214.13 | -183.25 | -105.80 | -117.81 | -94.12 | -69.71 | -30.75 | -16.06 | 10.65 | 33.13 | 35.57 | 35.57 | 20.88 | 9.52 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.3 | 0.6 | 0.9 | 1.1 | 1.5 | 0.8 | 1.1 | 1.4 | 1.8 | 2.4 | 1.5 | 1.5 | 1.5 | 1.5 | 3.0 | 3.0 | 3.0 | 3.0 | 7.0 | 7.0 | 7.0 | 7.0 | 3.0 | 3.0 | 3.0 | 3.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency